Published in Hepatitis Weekly, January 12th, 2004
According to recent research from Spain, "hepatocellular carcinoma (HCC) is the fifth most common cause of cancer, and its incidence is increasing worldwide because of the dissemination of hepatitis B and C virus infection. Patients with cirrhosis are at the highest risk and should be monitored every 6 months. Surveillance can lead to diagnosis at early stages, when the tumor might be curable by resection, liver transplantation, or percutaneous treatment."
"In the West and Japan, these treatments can be applied to 30% of patients, and result in 5-year survival rates higher...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly